Product Information
DILTIAZEM 24H ER(XR) 120 MG CP is a generic product labeled by NorthStar Rx LLC, priced at $0.3106 per EA under NDC 16714052302. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Aug 6, 1998. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714052302
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074943FDA Approved
8/6/1998
TE Code
AB2
On Market Since
2/22/2022
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(XR) 120 MG CP has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3106 per EA |
|---|---|
| All-time high | $0.4672 (Aug 16, 2023) |
| All-time low | $0.2531 (Nov 20, 2024) |
| 52-week high | $0.3990 |
| 52-week low | $0.3049 |
| Median price | $0.3992 |
| Average price | $0.3926 |
| Largest weekly change | -45.5% (Nov 20, 2024) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DILTIAZEM HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(XR) 120 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(XR) 120 MG CP, manufactured by NorthStar Rx LLC, is $0.3106 per EA (NDC 16714052302), effective Sep 30, 2026.
How has the price of DILTIAZEM 24H ER(XR) 120 MG CP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(XR) 120 MG CP has declined 31.2%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(XR) 120 MG CP?
Since Jul 13, 2022, the NADAC for DILTIAZEM 24H ER(XR) 120 MG CP has ranged from a low of $0.2531 (Nov 20, 2024) to a high of $0.4672 (Aug 16, 2023), with a median of $0.3992 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(XR) 120 MG CP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 24H ER(XR) 120 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DILTIAZEM 24H ER(XR) 120 MG CP?
DILTIAZEM 24H ER(XR) 120 MG CP (NDC 16714052302) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.